Medication Non-adherence among Liver Transplant Recipients Lauren S. JonesMarina Serper Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 24 October 2020 Pages: 327 - 336
Role of Immunomodulators in Functional Cure Strategies for HBV Benedikt BinderMaike HofmannRobert Thimme Hepatitis B (JK Lim, Section Editor) Open access 27 August 2020 Pages: 337 - 344
Chronic Hepatitis B and HIV Coinfection: a Continuing Challenge in the Era of Antiretroviral Therapy H. Nina Kim Hepatitis B (JK Lim, Section Editor) Open access 16 September 2020 Pages: 345 - 353
Diagnosis and Management of Occult Hepatitis B Infection Brian T. LeePonni V. Perumalswami Hepatitis B (JK Lim, Section Editor) 23 November 2020 Pages: 354 - 361
The Role of RNA Interference in Functional Cure Strategies for Chronic Hepatitis B Jeremy S NayagamZillah C CargillKosh Agarwal Hepatitis B (JK Lim, Section Editor) Open access 28 October 2020 Pages: 362 - 369
Role of Nucleic Acid Polymers and Entry Inhibitors in Functional Cure Strategies for HBV Sasan SakianiBilal AsifChristopher Koh Hepatitis B (JK Lim, Section Editor) 26 October 2020 Pages: 370 - 381
Alcohol Consumption in Non-Alcoholic Fatty Liver Disease: Safety and Disease Overlap Sheela S. Reddy Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 07 September 2020 Pages: 382 - 390
Current and Emerging Treatments for Non-alcoholic Steatohepatitis Christian L. HornAnvi C. TaNadege T. Gunn Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 25 August 2020 Pages: 391 - 401
Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease Audrey ThorpJonathan G. Stine Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 09 September 2020 Pages: 402 - 411
High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression Yedidya SaimanRoyce HooksRotonya M. Carr Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 01 September 2020 Pages: 412 - 419
The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease Chencheng XieDina Halegoua-DeMarzio Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 02 November 2020 Pages: 420 - 428
National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease Anita KrishnaraoCarmi S. Punzalan Fatty Liver Disease (D Halegoua-De Marzio, Section Editor) 03 November 2020 Pages: 429 - 436
LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging Evidence Anum AslamRichard Kinh Gian DoMishal Mendiratta-Lala Hepatic Cancer (N Parikh, Section Editor) 28 October 2020 Pages: 437 - 447
Genomic Landscape of HCC Nia AdenijiRenumathy Dhanasekaran Hepatic Cancer (N Parikh, Section Editor) 10 November 2020 Pages: 448 - 461
Racial and Sex Disparities in Hepatocellular Carcinoma in the USA Faith AjayiJenny JanNicole E. Rich Hepatic Cancer (N Parikh, Section Editor) 12 November 2020 Pages: 462 - 469
Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or Underuse Varun SaxenaNeil Mehta Hepatic Cancer (N Parikh, Section Editor) 04 November 2020 Pages: 470 - 477
A Contemporary Approach to Diagnosis and Treatment of Combined Hepatocellular-Cholangiocarcinoma Olga RaevskayaHenry AppelmanNataliya Razumilava Hepatic Cancer (N Parikh, Section Editor) 31 October 2020 Pages: 478 - 485
Spontaneous Bacterial Peritonitis and Secondary Bacterial Peritonitis—a Comprehensive Review Gabriela KuftinecJose Raul EstradaKalyan Ram Bhamidimarri Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 06 November 2020 Pages: 486 - 498
Correction to: Hepatitis B Core Antibody: Role in Clinical Practice in 2020 Robert G. GishSyed Abdul BasitUlrike Protzer Correction Open access 07 October 2020 Pages: 499 - 499